Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
1/4/2026
Essentia BioSciences Raises ~CNY 100M in Pre-A Round
1/3/2026
Lupin Enters Exclusive GLP-1 Deal With Gan & Lee
1/1/2026
Eli Lilly Slashes Mounjaro Price in China, Sparking Fierce Weight-Loss...
1/1/2026
Transcenta and EirGenix Partner to Expand Global Access to Affordable ...
1/1/2026
Youcare Files for Hong Kong IPO to Expand Innovative Drug Pipeline
1/1/2026
Zelgen and AbbVie Strike Global Licensing Deal for Trispecific TCE ZG0...
1/1/2026
Kousai Secures Strategic Financing to Advance Dendritic Cell Vaccine P...
1/1/2026
Moucellion Raises Pre-A Financing to Advance iPSC Therapies for Eye Di...
1/1/2026
InSilico Debuts on HKEX in Hong Kong's Largest Biotech IPO of the Year
12/30/2025
Suzhou Launches China's First Nuclear Medicine Demonstration Base
12/30/2025
Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...
12/30/2025
Novo Nordisk Cuts Price of Wegovy in China Ahead of Patent Expiry
12/30/2025
Adlai Nortye Grants ASK Pharma Exclusive Rights for Pan-RAS Inhibitor ...
12/30/2025
AstraZeneca's Fasenra Approved for EGPA in China
12/27/2025
Hemacell Completes Series B1 Financing to Advance Platelet Regeneratio...
12/27/2025
Chengdu Maxvax Biotech Completes D+ Financing Round
12/27/2025
LyncBio Therapeutics Completes Strategic Pre-A Financing Round
12/27/2025
Frontera's HKSE IPO Application Accepted
12/27/2025
Guangzhou Novaken Pharm Files for HKSE Main Board Listing
12/27/2025
Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
12/27/2025
Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...
12/23/2025
Aurobindo Pharma to Increase Stake in Chinese JV Luoxin Aurovitas
12/23/2025
Grand Secures China Rights to World's First Adrenaline Nasal Spray fr...
12/23/2025
Ipsen Expands Oncology Pipeline with Global Licensing of Simcere Zaimi...
12/23/2025
PepBio Raises Series A Financing to Advance AI-Driven Peptide Drug Pip...
12/22/2025
Windward Bio Licenses Long-Acting TSLP/IL-13 Bispecific WIN027 from Qy...
12/22/2025
Zelgen Files for Hong Kong IPO, Showcasing Commercial Portfolio and Mu...
12/22/2025
AstraZeneca Strengthens KRAS Oncology Strategy with Pan-KRAS Deal from...
12/22/2025
Rezubio Raises $20M Series A to Advance Membrane-Anchored Therapeutics...
12/19/2025
Insilico Targets US$292 Million in Hong Kong IPO to Advance AI-Driven ...
Page:
3
/
25
Total number of articles:
731
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit